Literature DB >> 29377283

Soluble CD14, CD163, and CD27 biomarkers distinguish ART-suppressed youth living with HIV from healthy controls.

Julie C Williams1, Xinrui Zhang2, Manju Karki1, Yueh-Yun Chi2, Shannon M Wallet3, Bret J Rudy4, Sharon L Nichols5, Maureen M Goodenow1, John W Sleasman6.   

Abstract

OBJECTIVE: To define inflammatory pathways in youth living with HIV infection (YLWH), assessments of biomarkers associated with lymphocyte and macrophage activation, vascular injury, or bone metabolism were performed in YLWH in comparison with healthy controls (HC).
DESIGN: Longitudinal multicenter study comparing biomarkers in YLWH suppressed on antiretroviral therapy (ART), those with ongoing viral replication, and HC were compared using single blood samples obtained at end of study.
METHODS: Twenty-three plasma proteins were measured by ELISA or multiplex assays. Principal component analysis (PCA) was used to define contributions of individual biomarkers to define outcome groups.
RESULTS: The study cohort included 129 predominantly African American, male participants, 21-25 years old at entry. Nine biomarkers of lymphocyte and macrophage activation and cardiovascular injury differed between HC and YLWH. Significant positive correlations were identified between lymphocyte and macrophage activation biomarkers among HC and YLWH. Correlations distinct to YLWH were predominantly between biomarkers of macrophage and vascular inflammation. PCA of outcome groups showed HC and suppressed YLWH clustering together for lymphocyte activation biomarkers, whereas macrophage activation markers showed all YLWH clustering distinct from HC. Cardiovascular biomarkers were indistinguishable across groups. Averaged variable importance projection to assess single biomarkers that maximally contribute to discriminate among outcome groups identified soluble CD27, CD14, and CD163 as the 3 most important with TNFα and LPS also highly relevant in providing separation.
CONCLUSIONS: Soluble inflammatory and lymphocyte biomarkers sufficiently distinguish YLWH from HC. Persistent macrophage activation biomarkers may provide a means to monitor consequences of HIV infection in fully suppressed YLWH. ©2018 Society for Leukocyte Biology.

Entities:  

Keywords:  HIV; adolescents; biomarker; chemokines; cytokines; inflammation; lymphocytes; macrophage

Mesh:

Substances:

Year:  2018        PMID: 29377283      PMCID: PMC6528780          DOI: 10.1002/JLB.3A0717-294RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  41 in total

1.  Potential roles of follicular dendritic cell-associated osteopontin in lymphoid follicle pathology and repair and in B cell regulation in HIV-1 and SIV infection.

Authors:  Qingsheng Li; Jeffrey D Lifson; Lijie Duan; Timothy W Schacker; Cavan Reilly; John Carlis; Jacob D Estes; Ashley T Haase
Journal:  J Infect Dis       Date:  2005-08-25       Impact factor: 5.226

Review 2.  Immunology and the REACH study: HIV immunology and preliminary findings. Reaching for Excellence in Adolescent Care and Health.

Authors:  B J Rudy; P A Crowley-Nowick; S D Douglas
Journal:  J Adolesc Health       Date:  2001-09       Impact factor: 5.012

3.  Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.

Authors:  Mark A Wallet; Carina A Rodriguez; Li Yin; Sara Saporta; Sasawan Chinratanapisit; Wei Hou; John W Sleasman; Maureen M Goodenow
Journal:  AIDS       Date:  2010-06-01       Impact factor: 4.177

4.  Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects.

Authors:  A De Milito; S Aleman; R Marenzi; A Sonnerborg; D Fuchs; M Zazzi; F Chiodi; Fuchs D
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

5.  Immune reconstitution and predictors of virologic failure in adolescents infected through risk behaviors and initiating HAART: week 60 results from the PACTG 381 cohort.

Authors:  Bret J Rudy; Jane C Lindsey; Patricia M Flynn; Ronald J Bosch; Craig M Wilson; Michael E Hughes; Steven D Douglas
Journal:  AIDS Res Hum Retroviruses       Date:  2006-03       Impact factor: 2.205

Review 6.  Inflammatory biomarkers in coronary artery disease.

Authors:  Epaminondas Zakynthinos; Nikolitsa Pappa
Journal:  J Cardiol       Date:  2009-01-29       Impact factor: 3.159

7.  Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons.

Authors:  Hui-Lee Wong; Ruth M Pfeiffer; Thomas R Fears; Roel Vermeulen; Shaoquan Ji; Charles S Rabkin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-12       Impact factor: 4.254

8.  Biochip array-based analysis of plasma cytokines in HIV patients with immunological and virological discordance.

Authors:  N Sachdeva; H S Yoon; K Oshima; D Garcia; K Goodkin; D Asthana
Journal:  Scand J Immunol       Date:  2007-06       Impact factor: 3.487

9.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection.

Authors:  Jason M Brenchley; David A Price; Timothy W Schacker; Tedi E Asher; Guido Silvestri; Srinivas Rao; Zachary Kazzaz; Ethan Bornstein; Olivier Lambotte; Daniel Altmann; Bruce R Blazar; Benigno Rodriguez; Leia Teixeira-Johnson; Alan Landay; Jeffrey N Martin; Frederick M Hecht; Louis J Picker; Michael M Lederman; Steven G Deeks; Daniel C Douek
Journal:  Nat Med       Date:  2006-11-19       Impact factor: 53.440

10.  HIV-1 activates macrophages independent of Toll-like receptors.

Authors:  Joseph N Brown; James J Kohler; Carter R Coberley; John W Sleasman; Maureen M Goodenow
Journal:  PLoS One       Date:  2008-12-02       Impact factor: 3.240

View more
  13 in total

1.  Tenofovir Has Minimal Effect on Biomarkers of Bone Health in Youth with HIV Receiving Initial Antiretroviral Therapy.

Authors:  Julie J Kim-Chang; Lorena Wilson; Cliburn Chan; Bernard Fischer; Guglielmo Venturi; Maureen M Goodenow; Grace Aldrovandi; Thomas J Weber; John W Sleasman
Journal:  AIDS Res Hum Retroviruses       Date:  2019-06-27       Impact factor: 2.205

2.  Monocyte count and soluble markers of monocyte activation in people living with HIV and uninfected controls.

Authors:  Andreas D Knudsen; Randa Bouazzi; Shoaib Afzal; Marco Gelpi; Thomas Benfield; Julie Høgh; Magda Teresa Thomsen; Marius Trøseid; Børge G Nordestgaard; Susanne D Nielsen
Journal:  BMC Infect Dis       Date:  2022-05-11       Impact factor: 3.667

3.  Immune Markers and Their Association with Bone Density in Children, Adolescents, and Young Adults with Perinatally Acquired HIV.

Authors:  Denise Jacobson; Jeremiah Zhe Liu; Jane C Lindsey; Stephanie Shiau; Brent Coull; Grace Aldrovandi
Journal:  AIDS Res Hum Retroviruses       Date:  2020-11-11       Impact factor: 2.205

4.  Trajectories of Depressive Symptoms, Neurocognitive Function, and Viral Suppression With Antiretroviral Therapy Among Youth With HIV Over 36 months.

Authors:  Jordan N Kohn; Matthew Shane Loop; Julie J Kim-Chang; Patricia A Garvie; John W Sleasman; Bernard Fischer; H Jonathon Rendina; Steven Paul Woods; Sharon L Nichols; Suzi Hong
Journal:  J Acquir Immune Defic Syndr       Date:  2021-06-01       Impact factor: 3.771

5.  Redistribution of brain glucose metabolism in people with HIV after antiretroviral therapy initiation.

Authors:  Zeping Wang; Maura M Manion; Elizabeth Laidlaw; Adam Rupert; Chuen-Yen Lau; Bryan R Smith; Avindra Nath; Irini Sereti; Dima A Hammoud
Journal:  AIDS       Date:  2021-07-01       Impact factor: 4.632

6.  Monocyte activation and gut barrier dysfunction in South African youth on antiretroviral therapy and their associations with endothelial dysfunction.

Authors:  Sahera Dirajlal-Fargo; Jiao Yu; Zainab Albar; Abdus Sattar; Sana Mahtab; Jennifer Jao; Landon Myer; Heather J Zar; Grace A McComsey
Journal:  AIDS       Date:  2020-09-01       Impact factor: 4.632

7.  Pre-cART Immune Parameters in People Living With HIV Might Help Predict CD8+ T-Cell Characteristics, Inflammation Levels, and Reservoir Composition After Effective cART.

Authors:  Jimena Salido; Alejandro Czernikier; César Trifone; María Laura Polo; María Inés Figueroa; Alejandra Urioste; Pedro Cahn; Omar Sued; Horacio Salomon; Natalia Laufer; Yanina Ghiglione; Gabriela Turk
Journal:  Pathog Immun       Date:  2021-10-01

8.  Persistently lower bone mass and bone turnover among South African children living with well controlled HIV.

Authors:  Yanhan Shen; Stephanie Shiau; Renate Strehlau; Megan Burke; Faeezah Patel; Cara T Johnson; Bridgette Rizkalla; Gallagher Dympna; Louise Kuhn; Ashraf Coovadia; Michael T Yin; Stephen M Arpadi
Journal:  AIDS       Date:  2021-11-01       Impact factor: 4.632

9.  Systemic Inflammation and the Increased Risk of Inflamm-Aging and Age-Associated Diseases in People Living With HIV on Long Term Suppressive Antiretroviral Therapy.

Authors:  Hemalatha Babu; Anoop T Ambikan; Erin E Gabriel; Sara Svensson Akusjärvi; Alangudi Natarajan Palaniappan; Vijila Sundaraj; Naveen Reddy Mupanni; Maike Sperk; Narayanaiah Cheedarla; Rathinam Sridhar; Srikanth P Tripathy; Piotr Nowak; Luke Elizabeth Hanna; Ujjwal Neogi
Journal:  Front Immunol       Date:  2019-08-27       Impact factor: 7.561

10.  Persistence of monocyte activation under treatment in people followed since acute HIV-1 infection relative to participants at high or low risk of HIV infection.

Authors:  Sophie Novelli; Camille Lécuroux; Cécile Goujard; Jacques Reynes; Agnès Villemant; Laurent Blum; Asma Essat; Véronique Avettand-Fenoël; Odile Launay; Jean-Michel Molina; Christine Bourgeois; Laurence Meyer
Journal:  EBioMedicine       Date:  2020-11-26       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.